Group 1 - The core viewpoint of the news highlights the trading performance and financial metrics of Kangtong Medical, indicating a mixed outlook with a notable decrease in revenue and profit [1][2]. - On August 1, Kangtong Medical's stock rose by 3.41%, with a trading volume of 83.28 million yuan. The financing buy-in amounted to 7.22 million yuan, while the financing repayment was 8.73 million yuan, resulting in a net financing outflow of 1.50 million yuan [1]. - As of August 1, the total balance of margin trading for Kangtong Medical was 43.36 million yuan, accounting for 2.73% of its market capitalization, which is above the 60th percentile of the past year [1]. Group 2 - The company reported a significant decline in revenue for the first quarter of 2025, with operating income of 24.29 million yuan, a year-on-year decrease of 68.09%, and a net profit attributable to shareholders of 1.58 million yuan, down 85.25% year-on-year [2]. - As of July 18, the number of shareholders for Kangtong Medical was 8,716, a decrease of 5.20% from the previous period, while the average circulating shares per person increased by 5.48% to 7,305 shares [2]. - Since its A-share listing, Kangtong Medical has distributed a total of 48.99 million yuan in dividends [3].
港通医疗8月1日获融资买入722.33万元，融资余额4335.62万元